MTOR and renal cell carcinoma: Likewise, FOXC1 activates the AMPK signaling pathway and inhibits the mTOR signaling pathway by upregulating the expression of ABHD5 to inhibit the growth and metastasis of RCC cells (Li J. et al., 2024).